Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alula is an active digital health company providing a multi-faceted online platform to support cancer patients, survivors, and caregivers. The service includes curated product recommendations, personalized registries, "cancer survival kits," communication tools for coordinating care/support, and content resources. The marketplace features products recommended by patients with guidance from medical experts. Founded by Liya Shuster-Bier after her own experience as both caregiver and patient, Alula aims to centralize resources that are otherwise scattered across the internet[1][3][4][10]. The company has raised at least $2.2 million in seed funding from notable investors including BBG Ventures and Thrive Capital[4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alula.